Therefore, our objectives were to assess the levels of expression of leptin and leptin receptors mRNA in PCa patient, BPH, and healthy subjects in order to evaluate their role as potential biomarkers for risk of PCa development and aggressiveness. Here, LEP is linked to benign prostatic hyperplasia.